Orphazyme (Denmark) Analysis

Orphazyme Stock Analysis Notes

The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orphazyme AS recorded a loss per share of 17.94. The entity had not issued any dividends in recent years. The firm had 1000:1 split on the 5th of December 2023. Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark. To find out more about Orphazyme AS contact MBA MSc at 45 39 17 82 72 or learn more at https://www.orphazyme.com.

Orphazyme AS Investment Alerts

Orphazyme Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orphazyme's market, we take the total number of its shares issued and multiply it by Orphazyme's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Orphazyme Profitablity

The company has Profit Margin (PM) of (2.76) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (15.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $15.38.

Technical Drivers

As of the 26th of November, Orphazyme holds the Semi Deviation of 3.23, coefficient of variation of 1370.18, and Risk Adjusted Performance of 0.0642. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orphazyme, as well as the relationship between them.

Orphazyme AS Price Movement Analysis

Orphazyme Outstanding Bonds

Orphazyme Predictive Daily Indicators

Orphazyme Forecast Models

Orphazyme's time-series forecasting models are one of many Orphazyme's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orphazyme's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Orphazyme prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orphazyme shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orphazyme. By using and applying Orphazyme Stock analysis, traders can create a robust methodology for identifying Orphazyme entry and exit points for their positions.

When running Orphazyme's price analysis, check to measure Orphazyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme is operating at the current time. Most of Orphazyme's value examination focuses on studying past and present price action to predict the probability of Orphazyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme's price. Additionally, you may evaluate how the addition of Orphazyme to your portfolios can decrease your overall portfolio volatility.